Big Drug Companies Plans To Sue Doctors For Prescribing Cheaper Alternatives
Doctors in the north east of England could be facing legal action from two of the world's largest pharmaceutical companies for offering sufferers of a serious eye condition the choice of a safe, effective and cheaper drug, according to the BMJ.
It is estimated that prescribing Avastin (bevacizumab) could save the cash-strapped NHS up to £13.5m (€15.4m) in the region over the next five years, and £500m a year if rolled out across the service.